Clinical trials
Completed Leukemia, Mast-Cell trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 1 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 4 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 4 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2018 | 1 |
| 2020 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 33 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Blueprint Medicines Corporation | 4 |
| Fred Hutchinson Cancer Center | 4 |
| Wake Forest University Health Sciences | 4 |
| Case Comprehensive Cancer Center | 2 |
| Jason Robert Gotlib | 2 |
| Mayo Clinic | 2 |
| National Cancer Institute (NCI) | 2 |
| Adelphi Values LLC | 1 |
| Alliance for Clinical Trials in Oncology | 1 |
| Children's Oncology Group | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Mast-Cell | 33 |
| Leukemia, Biphenotypic, Acute | 21 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 21 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 21 |
| Leukemia, Hairy Cell | 19 |
| Leukemia, Large Granular Lymphocytic | 19 |
| Burkitt Lymphoma | 18 |
| Lymphoma, Large B-Cell, Diffuse | 18 |
| Lymphoma, Large-Cell, Anaplastic | 18 |
| Lymphoma, Mantle-Cell | 18 |
Trials
Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.